Like Va Tech Wabag; buy Aurobindo Pharma: R Sreesankar

R Sreesankar, Head-Institutional Equities at Prabhudas Lilladher told CNBC-TV18, "I think the target for Va Tech Wabag is around Rs 1000. We see a sharp, good solid long term return coming in the stock as well. In the near term, it has not given the return. The company has got a long working capital cycle, their money is blocked but from a strong fundamental view point we still like it.""One can buy Aurobindo Pharma," he added.The company's trailing 12-month (TTM) EPS was at Rs 20.22 per share. (Sep, 2015). The stock's price-to-earnings (P/E) ratio was 33.48. The latest book value of the company is Rs 125.95 per share. At current value, the price-to-book value of the company was 5.38. The dividend yield of the company was 0.59 percent.